Agios to Present Clinical Data from its IDH Program at ASCO

World News: . []

CAMBRIDGE Mass May 15 2019 GLOBE NEWSWIRE -- Agios Pharmaceuticals Inc NASDAQAGIO a LINK  in the field of cellular metabolism to treat cancer and rare LINK  diseases today announced that data from its isocitrate dehydrogenase IDH progra...

More news and information about Agios Pharmaceuticals, Inc.

Published By:

Globe Newswire: 21:05 GMT Wednesday 15th May 2019

Published: .

Search for other references to "agios" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us